Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis

NCT03758716 is registered in ClinicalTrials.gov with Fountain Biopharma Inc. as lead sponsor.

NCT NCT03758716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03758716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis
Lead sponsor
Fountain Biopharma Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 3, 2017
Completion date
September 19, 2019
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis